{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:53:23Z","timestamp":1781488403302,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04331-5","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:48:33Z","timestamp":1777366113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating single-cell transcriptomics and machine learning to predict breast cancer prognosis and immunotherapy sensitivity: a study based on proliferating T cells"],"prefix":"10.1186","volume":"24","author":[{"given":"Yang","family":"Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"9472","key":"4331_CR1","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(05)66546-4","volume":"365","author":"U Veronesi","year":"2005","unstructured":"Veronesi U. Boyle, Peter, Goldhirsch, Aron, Orecchia, Roberto, and Viale, Giuseppe, Breast cancer. Lancet (London England). 2005;365(9472):1727\u201341.","journal-title":"Lancet (London England)"},{"issue":"3","key":"4331_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4331_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"4331_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41568-023-00604-3","volume":"23","author":"M Will","year":"2023","unstructured":"Will M, Liang J, Metcalfe C, Chandarlapaty S. Therapeutic resistance to anti-oestrogen therapy in breast cancer. Nat Rev Cancer. 2023;23(10):673\u201385. https:\/\/doi.org\/10.1038\/s41568-023-00604-3.","journal-title":"Nat Rev Cancer"},{"key":"4331_CR5","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.drup.2022.100851","volume":"63","author":"D Singh","year":"2022","unstructured":"Singh D, Assaraf YG, Gacche RN. Long non-coding RNA mediated drug resistance in breast cancer. Drug Resist Updat. 2022;63:100851. https:\/\/doi.org\/10.1016\/j.drup.2022.100851.","journal-title":"Drug Resist Updat"},{"issue":"10074","key":"4331_CR6","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389(10074):1134\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(16)31891-8.","journal-title":"Lancet"},{"issue":"3","key":"4331_CR7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10549-015-3341-3","volume":"150","author":"K Kast","year":"2015","unstructured":"Kast K, Link T, Friedrich K, Petzold A, Niedostatek A, Schoffer O, et al Impact of breast cancer subtypes and patterns of metastasis on outcome. Breast Cancer Res Treatm. 2015;150(3):621\u20139. https:\/\/doi.org\/10.1007\/s10549-015-3341-3.","journal-title":"Breast Cancer Res Treatm"},{"key":"4331_CR8","doi-asserted-by":"publisher","first-page":"108253","DOI":"10.1016\/j.pharmthera.2022.108253","volume":"237","author":"J So","year":"2022","unstructured":"So J, Young, Ohm, Joyce L, Stan, and, Yang, Li. Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. Pharmacol Ther. 2022;237:108253. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108253.","journal-title":"Pharmacol Ther"},{"key":"4331_CR9","doi-asserted-by":"publisher","first-page":"104683","DOI":"10.1016\/j.phrs.2020.104683","volume":"153","author":"KGK Deepak","year":"2020","unstructured":"Deepak KGK, Vempati R, Nagaraju G, Purnachandra, Dasari V, Ramesh S, Nagini, Rao DN, et al. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol Res. 2020;153:104683. https:\/\/doi.org\/10.1016\/j.phrs.2020.104683.","journal-title":"Pharmacol Res"},{"issue":"1","key":"4331_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert C, von Minckwitz G, Lederer D-ES, Heppner B, Weber BI. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40\u201350. https:\/\/doi.org\/10.1016\/S1470-2045(17)30904-X.","journal-title":"Lancet Oncol"},{"key":"4331_CR11","doi-asserted-by":"publisher","first-page":"104216","DOI":"10.1016\/j.ebiom.2022.104216","volume":"83","author":"NK Verma","year":"2022","unstructured":"Verma NK, Wong BH, Poh ZS, Udayakumar A, Verma R, Goh RK, Duggan SP, Shelat VG, Chandy KG, Grigoropoulos NF Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint. EBioMedicine. 2022;83:104216. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104216.","journal-title":"EBioMedicine"},{"issue":"4","key":"4331_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1152\/advan.00066.2013","volume":"37","author":"ND Pennock","year":"2013","unstructured":"Pennock ND, White JT, Cross EW, Cheney EE, Tamburini BA, Kedl RM. T cell responses: naive to memory and everything in between. Adv Physiol Educ. 2013;37(4):273\u201383. https:\/\/doi.org\/10.1152\/advan.00066.2013.","journal-title":"Adv Physiol Educ"},{"issue":"3","key":"4331_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00262-024-03630-8","volume":"73","author":"K Ntostoglou","year":"2024","unstructured":"Ntostoglou K, Theodorou SDP, Proctor T, Nikas IP, Awounvo S, Sepsa A, et al. Distinct profiles of proliferating CD8+\/TCF1\u2009+\u2009T cells and CD163+\/PD-L1\u2009+\u2009macrophages predict risk of relapse differently among treatment-na\u00efve breast cancer subtypes. Cancer Immunol Immunother. 2024;73(3):46. https:\/\/doi.org\/10.1007\/s00262-024-03630-8.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"4331_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s13402-021-00601-4","volume":"44","author":"NC Blessin","year":"2021","unstructured":"Blessin NC, Li W, Mandelkow T, Jansen HL, Yang C, Raedler JB, et al. Prognostic role of proliferating CD8(+) cytotoxic Tcells in human cancers. Cell Oncol (Dordr). 2021;44(4):793\u2013803. https:\/\/doi.org\/10.1007\/s13402-021-00601-4.","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"4331_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00262-024-03630-8","volume":"73","author":"K Ntostoglou","year":"2024","unstructured":"Ntostoglou K, Theodorou SDP, Proctor T, Nikas IP, Awounvo S, Sepsa A, et al. Distinct profiles of proliferating CD8+\/TCF1\u2009+\u2009T cells and CD163+\/PD-L1\u2009+\u2009macrophages predict risk of relapse differently among treatment-naive breast cancer subtypes. Cancer Immunol Immunother. 2024;73(3):46. https:\/\/doi.org\/10.1007\/s00262-024-03630-8.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"4331_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26(2):259\u201371. https:\/\/doi.org\/10.1093\/annonc\/mdu450.","journal-title":"Ann Oncol"},{"key":"4331_CR17","doi-asserted-by":"publisher","unstructured":"Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR. Targeting tumor microenvironment for cancer therapy. Int J Mol Sci. 2019;20(4). https:\/\/doi.org\/10.3390\/ijms20040840.","DOI":"10.3390\/ijms20040840"},{"issue":"6","key":"4331_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O, et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39(6):845\u2013e8657. https:\/\/doi.org\/10.1016\/j.ccell.2021.04.014.","journal-title":"Cancer Cell"},{"issue":"10","key":"4331_CR19","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"issue":"23","key":"4331_CR20","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1056\/NEJMra1215233","volume":"369","author":"SL Archer","year":"2013","unstructured":"Archer SL. Mitochondrial dynamics\u2013mitochondrial fission and fusion in human diseases. N Engl J Med. 2013;369(23):2236\u201351. https:\/\/doi.org\/10.1056\/NEJMra1215233.","journal-title":"N Engl J Med"},{"issue":"2","key":"4331_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","volume":"27","author":"T Wai","year":"2016","unstructured":"Wai T, Langer T. Mitochondrial Dynamics and Metabolic Regulation. Trends Endocrinol Metab. 2016;27(2):105\u201317. https:\/\/doi.org\/10.1016\/j.tem.2015.12.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"4331_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s12033-021-00445-1","volume":"64","author":"Y Jia","year":"2022","unstructured":"Jia Y, Chen X, Zhao D, Ma S. SNHG1\/miR-194-5p\/MTFR1 Axis Promotes TGFbeta1-Induced EMT, Migration and Invasion of Tongue Squamous Cell Carcinoma Cells. Mol Biotechnol. 2022;64(7):780\u201390. https:\/\/doi.org\/10.1007\/s12033-021-00445-1.","journal-title":"Mol Biotechnol"},{"key":"4331_CR23","doi-asserted-by":"publisher","first-page":"771824","DOI":"10.3389\/fcell.2021.771824","volume":"9","author":"Y Li","year":"2021","unstructured":"Li Y, Liu Y, Jin K, Dong R, Gao C, Si L, et al. Negatively Regulated by miR-29c-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma via the AMPK\/mTOR Signalling Pathway. Front Cell Dev Biol. 2021;9:771824. https:\/\/doi.org\/10.3389\/fcell.2021.771824.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"4331_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping NE, Rivadeneira DB, Menk AV, Vignali PDA, Ford BR, Rittenhouse NL, et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol. 2021;22(2):205\u201315. https:\/\/doi.org\/10.1038\/s41590-020-00834-9.","journal-title":"Nat Immunol"},{"issue":"1","key":"4331_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.18632\/aging.205338","volume":"16","author":"QY Li","year":"2024","unstructured":"Li QY, Guo Q, Luo WM, Luo XY, Ji YM, Xu LQ, et al. Overexpression of MTFR1 promotes cancer progression and drug-resistance on cisplatin and is related to the immune microenvironment in lung adenocarcinoma. Aging. 2024;16(1):66\u201388. https:\/\/doi.org\/10.18632\/aging.205338.","journal-title":"Aging"},{"issue":"6","key":"4331_CR26","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/ajcn\/77.6.1352","volume":"77","author":"HJ Powers","year":"2003","unstructured":"Powers HJ. Riboflavin (vitamin B-2) and health. Am J Clin Nutr. 2003;77(6):1352\u201360. https:\/\/doi.org\/10.1093\/ajcn\/77.6.1352.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"4331_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12935-021-02432-7","volume":"22","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li M, Cui Z, Chai D, Guan Y, Chen C, et al. Systematic analysis of the role of SLC52A2 in multiple human cancers. Cancer Cell Int. 2022;22(1):8. https:\/\/doi.org\/10.1186\/s12935-021-02432-7.","journal-title":"Cancer Cell Int"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04331-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:30:10Z","timestamp":1781487010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04331-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4331"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04331-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Ethics Committees of the First Affiliated Hospital of Wenzhou Medical University. The patients provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}